Patrys BBY Research - Target 12c, page-8

If you research the actual science of SM6 and its target GRP78, PAB does look very attractive.

"In addition to its chaperoning function, many data suggest that GRP78 is a multifunctional protein and plays critical roles in the resistance to chemotherapy agents, proliferation, invasion, and metastasis of many human cancers"

Source: http://www.hindawi.com/journals/bmri/2013/917296/

A number of peer reviewed references make similar claims as referenced in above link.

PAB has shown that SM6 kills cancer cells and may make them more sensitive to other treatments including chemotherapy. Its also shown so far to be safe and well tolerated. (2013,2014 asx announcements from PAB)

IMO the science validates SM6 and interest from a very large pharma validates the potential to commercialize it.

Payday might be coming, but you wont have to do any work, just sit and wait for it.

For the  conspiracy theorists ( i am not one):

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
0	26/07/2014	0.029	0.029	0.027	0.027	1,271,448
1	25/07/2014	0.029	0.029	0.027	0.027	1,271,448

Open high low close data and number of shares traded was exactly the same last week for two days......